As the pivotal enzyme driving de novo lipogenesis, FASN enables the heightened lipid biosynthesis that cancer cells critically depend on to fuel their rapid proliferation, a metabolic adaptation absent in normal cellular physiology.36 The gene discussed is FASN; the disease is cancer.